PF-03049423
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PF-03049423, covering 2011-08-09 to 2016-02-19. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke [Phase 2]